help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on October 6, 2005, doi:10.1165/rcmb.2005-0087OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0087OCv1
34/2/219    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armstrong, L.
Right arrow Articles by Millar, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, L.
Right arrow Articles by Millar, A. B.
American Journal of Respiratory Cell and Molecular Biology. Vol. 34, pp. 219-225, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0087OC

Contribution of TNF-{alpha} Converting Enzyme and Proteinase-3 to TNF-{alpha} Processing in Human Alveolar Macrophages

Lynne Armstrong, Sofia I. H. Godinho, Kay M. Uppington, Hayley A. Whittington and Ann B. Millar

Lung Research Group, Department of Clinical Science at North Bristol, University of Bristol, Bristol, United Kingdom

Correspondence and requests for reprints should be addressed to Ann Millar, M.D., Lung Research Group, Department of Clinical Science at North Bristol, University of Bristol, Paul O'Gorman Lifelife Centre, Southmead Hospital, Bristol BS10 5NB, UK. E-mail: ann.millar{at}bristol.ac.uk

Membrane-associated TNF-{alpha} cleavage is required to yield the 17.5-kD soluble product. This process is poorly understood in human cells, and no studies have related this process to the alveolar macrophage (AM). TNF-{alpha}–converting enzyme (TACE) is known to cleave TNF at the Ala-76–Val-77 site. We have evaluated the expression, regulation, and catalytic function of TACE in healthy human AMs. TACE was detected on the surface of AMs using flow cytometry. TACE protein can be upregulated by LPS (P = 0.036) and IFN-{gamma}. LPS-induced expression is downregulated by IL-10 (P = 0.04) and TNF-{alpha}. TACE regulation was observed at the mRNA level. TACE catalytic activity as assessed by cleavage of glutathione S-transferase–proTNF fusion protein correlates significantly with TACE protein expression (P = 0.04). However, cleavage and soluble TNF-{alpha} release by AMs was inhibited by matrix metalloproteinase and serine protease inhibitors, suggesting a role for a serine protease in this process. We confirmed the presence of proteinase-3 (PR-3) on the AM surface that was functionally capable of TNF cleavage. PR-3 mRNA expression was not found in AMs. However, we determined that PR-3 from neutrophil supernatants could bind to the AM membrane, suggesting that AM-derived PR-3 is from an exogenous source, which is important in the context of inflammation.

Key Words: inflammation • macrophages • TNF




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Zernichow, M. Abrink, J. Hallgren, M. Grujic, G. Pejler, and S. O. Kolset
Serglycin Is the Major Secreted Proteoglycan in Macrophages and Has a Role in the Regulation of Macrophage Tumor Necrosis Factor-{alpha} Secretion in Response to Lipopolysaccharide
J. Biol. Chem., September 15, 2006; 281(37): 26792 - 26801.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.